Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Socrates E Papapoulos

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Journal of Clinical Medicine|September 28, 2023
Similarities and Differences in the Management of Patients with Osteoporotic Vertebral Fractures and Those with Rebound-Associated Vertebral Fractures Following Discontinuation of DenosumabAthanasios D Anastasilakis, Polyzois Makras, Julien Paccou, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 28, 2004
Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal womenSocrates E Papapoulos, Sara A Quandt, Uri A Liberman, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 22, 2019
Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical TrialAthanasios D Anastasilakis, Socrates E Papapoulos, Stergios A Polyzos, et al.
The Journal of Biological Chemistry|November 8, 2002
Peroxisome proliferator-activated receptor gamma (PPARgamma ) as a molecular target for the soy phytoestrogen genisteinZhi-Chao Dang, Valérie Audinot, Socrates E Papapoulos, et al.
Calcified Tissue International|February 10, 2011
No effect of rosuvastatin in the zoledronate-induced acute-phase responsePolyzois Makras, Athanasios D Anastasilakis, Stergios A Polyzos, et al.
Bone|May 15, 2012
Serum sclerostin levels in Paget's disease and prostate cancer with bone metastases with a wide range of bone turnoverMaria P Yavropoulou, Antoon H van Lierop, Neveen A T Hamdy, et al.
International Journal of Molecular Sciences|March 6, 2021
Increased Bone Resorption during Lactation in PycnodysostosisIneke D C Jansen, Socrates E Papapoulos, Nathalie Bravenboer, et al.
Bone|January 4, 2011
Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and featuresAndrea Giusti, Neveen A T Hamdy, Olaf M Dekkers, et al.
Bone|January 25, 2005
Severe hypophosphatemic osteomalacia in hormone-refractory prostate cancer metastatic to the skeleton: natural history and pitfalls in managementRob C M Pelger, Guus A B Lycklama A Nijeholt, Socrates E Papapoulos, et al.
Bone|December 2, 2008
Inhibition of bone resorption and growth of breast cancer in the bone microenvironmentJeroen T Buijs, Ivo Que, Clemens W G M Löwik, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Journal of Clinical Medicine|September 28, 2023
Similarities and Differences in the Management of Patients with Osteoporotic Vertebral Fractures and Those with Rebound-Associated Vertebral Fractures Following Discontinuation of DenosumabAthanasios D Anastasilakis, Polyzois Makras, Julien Paccou, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 28, 2004
Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal womenSocrates E Papapoulos, Sara A Quandt, Uri A Liberman, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 22, 2019
Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical TrialAthanasios D Anastasilakis, Socrates E Papapoulos, Stergios A Polyzos, et al.
The Journal of Biological Chemistry|November 8, 2002
Peroxisome proliferator-activated receptor gamma (PPARgamma ) as a molecular target for the soy phytoestrogen genisteinZhi-Chao Dang, Valérie Audinot, Socrates E Papapoulos, et al.
Calcified Tissue International|February 10, 2011
No effect of rosuvastatin in the zoledronate-induced acute-phase responsePolyzois Makras, Athanasios D Anastasilakis, Stergios A Polyzos, et al.
Bone|May 15, 2012
Serum sclerostin levels in Paget's disease and prostate cancer with bone metastases with a wide range of bone turnoverMaria P Yavropoulou, Antoon H van Lierop, Neveen A T Hamdy, et al.
International Journal of Molecular Sciences|March 6, 2021
Increased Bone Resorption during Lactation in PycnodysostosisIneke D C Jansen, Socrates E Papapoulos, Nathalie Bravenboer, et al.
Bone|January 4, 2011
Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and featuresAndrea Giusti, Neveen A T Hamdy, Olaf M Dekkers, et al.
Bone|January 25, 2005
Severe hypophosphatemic osteomalacia in hormone-refractory prostate cancer metastatic to the skeleton: natural history and pitfalls in managementRob C M Pelger, Guus A B Lycklama A Nijeholt, Socrates E Papapoulos, et al.
Bone|December 2, 2008
Inhibition of bone resorption and growth of breast cancer in the bone microenvironmentJeroen T Buijs, Ivo Que, Clemens W G M Löwik, et al.
Pageof 8